What is the FDA label indication for Cefdinir?

Cefdinir is a cephalosporin antibiotic that is primarily indicated for the treatment of specific bacterial infections. The FDA has specifically labeled it for use in treating acute otitis media (ear infections), pharyngitis (sore throat), and tonsillitis (inflammation of the tonsils) caused by susceptible strains of bacteria. This makes it effective in managing infections that are commonly seen in both pediatric and adult populations, particularly in the context of respiratory tract infections.

The other options relate to conditions that are not treated with Cefdinir. Acne vulgaris is typically managed with topical agents or other systemic medications, chronic heart failure requires cardiovascular medications rather than antibiotics, and rheumatoid arthritis is treated with anti-inflammatory drugs or disease-modifying antirheumatic drugs, not antibiotics like Cefdinir. Hence, the focus of Cefdinir's FDA indication accurately aligns with option A.